Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer

Fig. 4

Stratified prognostic analysis of the TNBC-IMRGs signature. a-h The survival differences between high- and low- risk groups stratified by clinical variables: a, b age (≤ 55 and > 55), c, d node (N0 and N1-3), e, f tumor (T1-2 and T3-4), g, h stage (stage I-II and stage III-IV). Time: days

Back to article page